UK Markets close in 6 hrs 7 mins

Sanofi (SAN.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
85.61-0.16 (-0.19%)
As of 11:08AM CEST. Market open.
Full screen
Previous close85.77
Open84.60
Bid0.00 x 0
Ask0.00 x 0
Day's range83.90 - 86.03
52-week range74.92 - 91.14
Volume324,800
Avg. volume1,650,471
Market cap107.077B
Beta (5Y monthly)0.40
PE ratio (TTM)8.84
EPS (TTM)9.68
Earnings date28 Oct 2021
Forward dividend & yield3.20 (3.64%)
Ex-dividend date05 May 2021
1y target estN/A
  • Globe Newswire

    Sanofi : Strong Q3 performance drives guidance upgrade to around 14% business EPS growth at CER(1)

    Paris, October 28, 2021 Strong Q3 performance drives guidance upgrade to around 14% business EPS growth at CER(1) Q3 2021 sales grew double digit to €10.4 billion (up 10.1%) due to strong growth from Dupixent®, Vaccines and CHC Specialty Care sales increased 20.2% with strong contribution from Dupixent® (+54.6% to €1,410 million)Vaccines up 16.5%, with record quarterly sales driven by differentiated flu vaccines and meningitis franchise recovery CHC increased 11.1% driven by growth of Pain care

  • Globe Newswire

    Sanofi: Information concerning the total number of voting rights and shares - September 2021

    Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority) Sanofia French société anonyme with a registered share capital of 2,526,866,030 €Registered office : 54, rue La Boétie - 75008 Paris - FranceRegistered at the Paris Commercial and Companies Registry under n

  • Zacks

    Biotech Stock Roundup: BMY's Q3 Earnings Beat, MRNA's Vaccine Updates & More

    Earnings and other updates from bigwigs like Bristol Myers (BMY) and Moderna (MRNA) have been the biotech sector's few key highlights during the past week.